Shenmai injection improves the postoperative immune function of papillary thyroid carcinoma patients by inhibiting differentiation into Treg cells via miR ‐103/GPER1 axis

Drug Development Research, EarlyView.

Source: Drug Development Research - September 29, 2018 Category: Drugs & Pharmacology Authors: Tie Fang, Jianjun Li, Xianjiang Wu Source Type: research